Clinical Trial (Interventional)

Results 1 - 25 of 409
Public Title Status Date Registered
SMS for HPN
PHRR130226-000054
Completed 26 Feb 2013
Safety, Reactogenicity and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants . . .
PHRR121206-000029
Completed 06 Dec 2012
Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split . . .
PHRR130221-000052
Completed 21 Feb 2013
Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizur . . .
PHRR121211-000034
Terminated 11 Dec 2012
A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia . . .
PHRR121210-000032
Ongoing 10 Dec 2012
Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia
PHRR121114-000015
Ongoing 14 Nov 2012
Study to evaluate over a prolonged period of time, the safety and the efficacy of a treatment with Reslizumab (at a dose of 3mg/kg) for patients suffering from eosinophilic asthma who completed a prio . . .
PHRR130117-000043
Ongoing 17 Jan 2013
A Phase III trial to compare the safety and efficacy of lapatinib plus trastuzumab plus an aromatase inhibitor (AI) versus trastuzumab plus an AI versus lapatinib plus an AI as first-line therapy in p . . .
PHRR121210-000033
Ongoing 10 Dec 2012
A Study to Investigate How Effective and Safe Solifenacin Liquid Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non . . .
PHRR121119-000017
Ongoing 19 Nov 2012
A study to investigate how safe and effective solifenacin fluid is in treating children/adolescents with symptoms of overactive bladder (OAB) who completed study 905-CL-076 (LEOPARD) . . .
PHRR121119-000018
Ongoing 19 Nov 2012
Study of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and Adults . . .
PHRR121203-000027
Completed 03 Dec 2012
Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV . . .
PHRR121127-000021
Ongoing 27 Nov 2012
Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen
PHRR121128-000024
Ongoing 28 Nov 2012
A prospective, open label, 24-week trial of methylcobalamin in the treatment of diabetic polyneuropathy . . .
PHRR121210-000031
Completed 10 Dec 2012
A multi-centre, double-blind, randomised, parallel-group, active controlled study to evaluate the efficacy, safety and tolerability of tafenoquine (SB-252263, WR238605) in subjects with Plasmodium viv . . .
PHRR130102-000040
Pending 02 Jan 2013
Safety and Efficacy of Tiotropium Inhalation Solution (2.5mcg and 5mcg) in Patients of 1 to 5 years old with persistent asthma (205.443) . . .
PHRR121213-000035
Completed 13 Dec 2012
Efficacy and Safety of tiotropium inhalation solution (2.5 μg and 5 μg once daily) over 12 weeks as add-on controller therapy on top of usual care in adolescents (12 to 17 years old) with severe per . . .
PHRR121214-000036
Completed 14 Dec 2012
A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus Platinum And Paclitaxel or With Pemetrexed Plus Platinum in Patients With Non-Squamous Non-Small Cell Lung Cancer . . .
PHRR130207-000049
Ongoing 07 Feb 2013
A Phase III, Observer-blind, Randomized, Multi-center Study to Evaluate the Safety, Tolerability, Immunogenicity, and Clinical Efficacy of Revaccination with Fluad Compared to the Non-Adjuvanted Triva . . .
PHRR130225-000053
Terminated 25 Feb 2013
Study of a 4-phasic oral contraceptive for the treatment of heavy menstrual bleeding
PHRR130110-000042
Ongoing 10 Jan 2013
A Multicenter, Double-Blind, Double-Dummy, Follow-Up Study Evaluating The Long-Term Safety Of Lacosamide (200 To 600mg/Day) In Comparison With Carbamazepine (400 To 1200mg/Day), Used As Monotherapy In . . .
PHRR130709-000092
Completed 09 Jul 2013
A Multicenter, Double-Blind, Randomized, Parallel-Group, Phase III Study to Compare the Efficacy and Safety of Hercules Versus Herceptin® in Patients with HER2+Metastatic Breast Cancer . . .
PHRR130220-000051
Ongoing 20 Feb 2013
Phase 3 study on schizoprenia
PHRR130306-000056
Completed 06 Mar 2013
Asenapine bipolar 1 disorder recurrence prevention trial
PHRR131218-000152
Completed 18 Dec 2013
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE) . . .
PHRR130611-000077
Completed 11 Jun 2013

Copyright © One Window Project 2020. All rights reserved.